Author Correction: The current state and future directions of RNAi-based therapeutics

Ryan L Setten^{1

2}, John J Rossi^{1

2}, Si-Ping Han^{3

4}

Affiliations

¹ Department of Molecular and Cellular Biology, Beckman Research Institute, City of Hope, Duarte, CA, USA.
² Irell and Manella Graduate School of Biological Sciences, City of Hope, Duarte, CA, USA.
³ Department of Molecular and Cellular Biology, Beckman Research Institute, City of Hope, Duarte, CA, USA. sihan@coh.org.
⁴ Materials and Process Simulation Center, California Institute of Technology, Pasadena, CA, USA. sihan@coh.org.

Published Erratum

Ryan L Setten et al. Nat Rev Drug Discov. 2020 Apr.

. 2020 Apr;19(4):290.

doi: 10.1038/s41573-019-0027-2.

Ryan L Setten^{1

2}, John J Rossi^{1

2}, Si-Ping Han^{3

4}

¹ Department of Molecular and Cellular Biology, Beckman Research Institute, City of Hope, Duarte, CA, USA.
² Irell and Manella Graduate School of Biological Sciences, City of Hope, Duarte, CA, USA.
³ Department of Molecular and Cellular Biology, Beckman Research Institute, City of Hope, Duarte, CA, USA. sihan@coh.org.
⁴ Materials and Process Simulation Center, California Institute of Technology, Pasadena, CA, USA. sihan@coh.org.

Abstract

Errors in the alignment and structure of the siRNN and in the structure of the sisiRNA in the original version of Fig. 3 have been corrected.

The current state and future directions of RNAi-based therapeutics.
Setten RL, Rossi JJ, Han SP. Setten RL, et al. Nat Rev Drug Discov. 2019 Jun;18(6):421-446. doi: 10.1038/s41573-019-0017-4. Nat Rev Drug Discov. 2019. PMID: 30846871 Review.